Apoor Gami, MD
Clinical Cardiac Electrophysiology · Elmhurst, ILNPI 1326026840
Payments from drug & device makers
Across 324 payments — averaging $336.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cardiofocus, Inc.$32K
- Jazz Pharmaceuticals Inc.$24K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$19K
- Kestra Medical Technology Services, Inc.$15K
- Sanofi-aventis U.S. LLC$7K
- Stryker$4K
- plus $7K from 30 others
What the payments were for
- Consulting fees$56,50752%
- Speaking & faculty fees$38,50535%
- Travel & lodging$4,7944%
- Food & beverage$9,2338%
- Education$650%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cardiofocus, Inc. | 31 | $32,265 |
| Jazz Pharmaceuticals Inc. | 18 | $24,062 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 46 | $18,629 |
| Kestra Medical Technology Services, Inc. | 14 | $15,374 |
| Sanofi-aventis U.S. LLC | 11 | $7,163 |
| Stryker | 3 | $4,400 |
| Altathera Pharmaceuticals LLC | 4 | $2,249 |
| Atricure, Inc. | 10 | $750 |
| Boston Scientific | 34 | $669 |
| Pfizer | 26 | $559 |
| Novartis | 27 | $490 |
| Abbott | 12 | $431 |
| Amgen | 15 | $329 |
| Boehringer Ingelheim | 9 | $230 |
| Novo Nordisk | 8 | $191 |
| Acutus Medical, Inc. | 1 | $177 |
| E.r. Squibb & Sons, L.L.C. | 11 | $160 |
| Impulse Dynamics (USA) Inc. | 1 | $142 |
| Medtronic(3 entities) | 7 | $126 |
| Chiesi USA, Inc. | 7 | $113 |
| Acist Medical Systems, Inc. | 1 | $85 |
| Johnson & Johnson | 5 | $73 |
| Heartflow, Inc. | 3 | $68 |
| Lundbeck LLC | 3 | $59 |
| Itamar Medical Inc | 3 | $52 |
| Elutia, Inc. | 3 | $50 |
| Cvrx, Inc. | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 2 | $28 |
| Philips North America LLC | 1 | $22 |
| Shockwave Medical, Inc | 1 | $21 |
| Cardiva Medical, Inc. | 1 | $21 |
| Imperative Care, Inc | 1 | $21 |
| Lexicon Pharmaceuticals, Inc. | 1 | $19 |
| Tactile Systems Technology Inc | 1 | $18 |
| Teleflex LLC | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HeartLight System$31,853
- XYWAV$23,540
- LifeVest$17,574
- Assure WCD$15,218
- XYREM$14,168
- ZIPSEAL 16 SURGICAL SKIN CLOSURE KIT$6,000
- ZIPSEAL 24 SURGICAL SKIN CLOSURE KIT$4,000
- Sotalol Hydrochloride$2,217
- MULTAQ$2,153
- ZIP DS DRESSING SHIELD$2,000
- OPTIMIZER$284
- SYNERGY ABLATION SYSTEM$244
- EnSite Precision Cardiac Mapping System$133
- VYNDAQEL$103
How this compares
$109,104 in reported general payments places this provider in the 75th percentile of 158 clinical cardiac electrophysiology providers in Illinois.
See all clinical cardiac electrophysiology providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 680 | $777,868 |
| XareltoRivaroxaban | 356 | $417,385 |
| MultaqDronedarone Hcl | 145 | $214,936 |
| EntrestoSacubitril/Valsartan | 147 | $194,380 |
| Propafenone Hcl ErPropafenone Hcl | 115 | $20,043 |
| BrilintaTicagrelor | 26 | $18,081 |
| Metoprolol Succinate | 710 | $13,565 |
| Praluent PenAlirocumab | 18 | $10,648 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 31 | $10,104 |
| Repatha SureclickEvolocumab | 18 | $10,037 |
| Dofetilide | 49 | $10,012 |
| PradaxaDabigatran Etexilate Mesylate | 11 | $5,550 |
| SotalolSotalol Hcl | 222 | $5,331 |
| Rosuvastatin Calcium | 252 | $4,538 |
| Atorvastatin Calcium | 361 | $4,015 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $559 | $777,868680 claims |
| Johnson & JohnsonXarelto | $73 | $417,385356 claims |
| Sanofi-aventis U.S. LLCMultaq | $7,163 | $214,936145 claims |
| NovartisEntresto | $490 | $194,380147 claims |
| Boehringer IngelheimPradaxa | $230 | $5,55011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 158 clinical cardiac electrophysiology providers in Illinois.
Other clinical cardiac electrophysiology in Elmhurst
- Cash CaseyElmhurst$287K
- Roderick TungChicago$2.3M
- Bradley KnightChicago$1.6M
- Mark MetzlEvanston$1.5M
- Moeen SaleemNaperville$1.2M
- Ziad IssaSpringfield$1.2M
- Henry HuangGeneva$955K
- Mansour RazminiaPalos Heights$930K
- Gaurav UpadhyayChicago$785K
- William SpearEvergreen Park$675K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.